Metabolism of ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing β-D-glucosidase from Bifidobacterium longum H-1

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 4, 2012, Pages 573-581

  Jung, Il Hoon ^a   Lee, Jeong Hoon ^a   Hyun, Yang Jin ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

D glucosidase; D glucosidase coding gene; Bifidobacterium longum H 1; Ginsenoside Rb1; Intestinal microflora; Metabolism

Indexed keywords

ARBUTIN; ARCTIIN; BETA GLUCOSIDASE; GINSENOSIDE RB 1; LOGANIN;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM LONGUM; CONTROLLED STUDY; DRUG MECHANISM; DRUG METABOLISM; ENZYME ACTIVITY; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; GENE SEQUENCE; GENE SYNTHESIS; GENETIC CODE; GENETIC IDENTIFICATION; HUMAN; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; INTESTINE FLORA; MALE; METABOLIC ACTIVATION; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; SEQUENCE HOMOLOGY;

ADULT; AGED; BETA-GLUCOSIDASE; BIFIDOBACTERIUM; CLONING, MOLECULAR; ESCHERICHIA COLI; FECES; FEMALE; GINSENOSIDES; HUMANS; INTESTINES; MALE; MIDDLE AGED; PANAX; YOUNG ADULT;

EID: 84859476056     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.35.573     Document Type: Article

References (38)

1. Kim DH. Intestinal microflora activate the pharmacological effects of herbal medicines. Nat. Prod. Sci., 8, 35-43 (2002).
2. Kobashi K, Akao T. Relation of intestinal bacteria to pharmacological effect of glycosides. Biosci. Microflora, 16, 1-7 (1997).
3. Kobashi K, Nakata H, Takebe H, Terasawa K. Relation of intestinal bacteria to pharmacological effect of glycosides. Wakan-yakukaishi, 1, 166-167 (1984).
4. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch. Pharm. Res., 27, 61-67 (2004).
5. Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK, Kim DH. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J. Microbiol. Biotechnol., 18, 1109-1114 (2008).
6. Lee DS, Kim YS, Ko CN, Cho KH, Bae HS, Lee KS, Kim JJ, Park EK, Kim DH. Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res., 25, 165-169 (2002).
7. Yim JS, Kim YS, Moon SK, Cho KH, Bae HS, Kim JJ, Park EK, Kim DH. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol. Pharm. Bull., 27, 1580-1583 (2004).
8. Nagai M, Ando T, Tanaka N, Tanaka O, Shibata S. Chemical studies on the oriental plant drugs: XXVIII. Saponins and sapogenins of ginseng; stereochemistry of sapogenin of ginsenoside Rb1, Rb2 and Rc. Chem. Pharm. Bull., 20, 1212-1216 (1972).
9. Shibata S, Fujita M, Itokawa H, Tanaka O, Ishii T. Studies on the constituents of Japanese and Chinese crude drugs. XI. Panaxadiol, a sapogenin of ginseng roots. Chem. Pharm. Bull., 11, 759-761 (1963).
10. Joh EH, Lee IA, Jung IH, Kim DH. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation - the key step of inflammation. Biochem. Pharmacol., 82, 278-286 (2011).
11. Chen CF, Chiou WF, Zhang JT. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol. Sin., 29, 1103-1108 (2008).
12. Wakabayashi C, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Oncol. Res., 9, 411-417 (1989).
13. Shin YW, Kim DH. Antipruritic effect of ginsenoside rb1 and compound k in scratching behavior mouse models. J. Pharmacol. Sci., 99, 83-88 (2005).
14. Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration - measurement of compound K by enzyme immunoassay - . Biol. Pharm. Bull., 21, 245-249 (1988).
15. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol., 50, 1155-1160 (1998).
16. Bae EA, Park SY, Kim DH. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull., 23, 1481-1485 (2000).
17. Lee J, Lee E, Kim DH, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J. Ethnopharmacol., 122, 143-148 (2009).
18. Tawab MA, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos., 31, 1065-1071 (2003).
19. Choo MK, Park EK, Han MJ, Kim DH. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Planta Med., 69, 518-522 (2003).
20. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol. Pharm. Bull., 25, 743-747 (2002).
21. Bae EA, Kim NY, Han MJ, Choo MK, Kim DH. Transformation of ginsenosides to compound K (IH-901) by lactic acid bacteria of human intestine. J. Microbiol. Biotechnol., 13, 9-14 (2003).
22. Lee IA, Joh EH, Kim DH. Arctigenin isolated from the seeds of Arctium lappa ameliorates memory deficits in mice. Planta Med., 77, 1525-1527 (2011).
23. Jung K, Lee B, Han SJ, Ryu JH, Kim DH. Mangiferin ameliorates scopolamine-induced learning deficits in mice. Biol. Pharm. Bull., 32, 242-246 (2009).
24. Han YO, Han MJ, Park SH, Kim DH. Protective effects of kakkalide from Flos puerariae on ethanol-induced lethality and hepatic injury are dependent on its biotransformation by human intestinal microflora. J. Pharmacol. Sci., 93, 331-336 (2003).
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem., 72, 248-254 (1976).
26. Ham JS, Lee T, Byun MJ, Lee KT, Kim MK, Han GS, Jeong SG, Oh MH, Kim DH, Kim H. Complete genome sequence of Bifidobacterium longum subsp. longum KACC 91563. J. Bacteriol., 193, 5044 (2011).
27. Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Crit. Rev. Food Sci. Nutr., 31, 299-331 (1992).
28. Esen A. β-Glucosidase: Biochemistry and Molecular Biology. (Esen A ed.), American Chemical Society, Washington DC, pp. 1-13 (1993).
29. Ghosh P, Pamment NB, Martin WRB. Simultaneous saccharification and fermentation of cellulose: Effect of beta-D-glucosidase activity and ethanol inhibition of cellulases. Enzyme Microb. Technol., 4, 425-430 (1982).
30. Lei V, Amoa-Awua WK, Brimer L. Degradation of cyanogenic glycosides by Lactobacillus plantarum strains from spontaneous cassava fermentation and other microorganisms. Int. J. Food Microbiol., 53, 169-184 (1999).
31. Li X, Huo C, Wang Q, Zhang X, Sheng X, Zhang L. Microbial metabolism of loganin by intestinal bacteria and identification of new metabolites in rat. Biomed. Chromatogr., 22, 367-373 (2008).
32. Kim JY, Kim BK, Lee YS, Kang CS, Ahn JH, Lim YH. Cloning of β-Glucosidase gene from Streptomyces coelicolor A3(2) and characterization of the recombinant β-glucosidase expressed in Escherichia coli. Kor. J. Microbiol. Biotechnol., 37, 99-104 (2009).
33. Nunoura N, Ohdan K, Tanaka K, Tamaki H, Yano T, Inui M, Yukawa H, Yamamoto K, Kumagai H. Cloning and nucleotide sequence of the beta-D-glucosidase gene from Bifidobacterium breve clb, and expression of beta-D-glucosidase activity in Escherichia coli. Biosci. Biotechnol. Biochem., 60, 2011-2018 (1996).
34. Kuo LC, Lee KT. Cloning, expression, and characterization of two beta-glucosidases from isoflavone glycoside-hydrolyzing Bacillus subtilis natto. J. Agric. Food Chem., 56, 119-125 (2008).
35. Yang L, Akao T, Kobashi K, Hattori M. Purification and characterization of a novel sennoside-hydrolyzing beta-glucosidase from Bifidobacterium sp. strain SEN, a human intestinal anaerobe. Biol. Pharm. Bull., 19, 705-709 (1996).
36. Kim DH, Sohng IS, Kobashi K, Han MJ. Purification and characterization of beta-glucosidase from Bacteroides JY-6, a human intestinal bacterium. Biol. Pharm. Bull., 19, 1121-1125 (1996).
37. Kim Y, Hollenbaugh JA, Kim DH, Kim B. Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat. PLoS ONE, 6, e21781 (2011).
38. Ye R, Zhang X, Kong X, Han J, Yang Q, Zhang Y, Chen Y, Li P, Liu J, Shi M, Xiong L, Zhao G. Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience, 178, 169-180 (2011).